Daina Graybosch
Stock Analyst at Leerink Partners
(0)
# 4511
Out of 5,218 analysts
130
Total ratings
32.18%
Success rate
-13.23%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
LAVA Therapeutics | Downgrades: Market Perform | 11 2 | 1.12 | 78.57% | 6 | Dec 12, 2024 | |
Bolt Biotherapeutics | Downgrades: Market Perform | 3 1 | 0.52 | 92.31% | 8 | May 15, 2024 | |
2seventy bio | Upgrades: Outperform | 5 18 | 3.27 | 450.46% | 5 | Jan 31, 2024 | |
Arcellx | Maintains: Outperform | 35 39 | 83.86 | -53.49% | 5 | Mar 30, 2023 | |
Nektar Therapeutics | Maintains: Market Perform | 5 3 | 1 | 200% | 10 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 120 122 | 102.09 | 19.5% | 18 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 14 | 1.22 | 1047.54% | 4 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 62 10 | 1.82 | 449.45% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 60 | 2.13 | 2716.9% | 7 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 9 | 3.06 | 194.12% | 10 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 38 | 16.11 | 135.88% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 8 | 5.41 | 47.87% | 4 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 223 224 | 120.2 | 86.36% | 16 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 2.35 | 1176.6% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 21 7 | n/a | n/a | 4 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 59 | 7.67 | 669.23% | 7 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 17 | 1.66 | 924.1% | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 25 2 | n/a | n/a | 6 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 9 | 1.61 | 459.01% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | n/a | n/a | 2 | Apr 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 68 | n/a | n/a | 1 | Dec 11, 2019 |